101 related articles for article (PubMed ID: 1309205)
21. Aortic wall injury following intraoperative irradiation.
Gillette EL; Powers BE; McChesney SL; Withrow SJ
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1401-6. PubMed ID: 3198439
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative radiation therapy to the upper mediastinum and nerve-sparing three-field lymphadenectomy followed by external beam radiotherapy for patients with thoracic esophageal carcinoma.
Hosokawa M; Shirato H; Ohara M; Kagei K; Hashimoto S; Nishino S; Takamura A; Arimoto T
Cancer; 1999 Jul; 86(1):6-13. PubMed ID: 10391557
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
25. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07.
Byhardt RW; Pajak TF; Emami B; Herskovic A; Doggett RS; Olsen LA
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):459-68. PubMed ID: 8390420
[TBL] [Abstract][Full Text] [Related]
26. Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.
Langer CJ; Curran WJ; Keller SM; Catalano R; Fowler W; Blankstein K; Litwin S; Bagchi P; Nash S; Comis R
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):469-78. PubMed ID: 8390421
[TBL] [Abstract][Full Text] [Related]
27. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: neurologic and electrophysiologic study.
Vujaskovic Z; Gillette SM; Powers BE; Stukel TA; Larue SM; Gillette EL; Borak TB; Scott RJ; Weiss J; Colacchio TA
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):125-31. PubMed ID: 12118540
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
29. [Intraoperative radiotherapy during plastic surgery for lung cancer].
Zyrianov BN; Khodkevich BS; Kolomiets SA; Miller SV
Vopr Onkol; 2000; 46(2):211-4. PubMed ID: 10853424
[TBL] [Abstract][Full Text] [Related]
30. Late radiation response of canine mediastinal tissues.
Gillette SM; Gillette EL; Shida T; Boon J; Miller CW; Powers BE
Radiother Oncol; 1992 Jan; 23(1):41-52. PubMed ID: 1736331
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma.
Murakami M; Kuroda Y; Nakajima T; Okamoto Y; Mizowaki T; Kusumi F; Hajiro K; Nishimura S; Matsusue S; Takeda H
Dis Esophagus; 1999; 12(4):270-5. PubMed ID: 10770361
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
33. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
De Ruysscher D; Wanders R; van Haren E; Hochstenbag M; Geraedts W; Pitz C; Simons J; Boersma L; Verschueren T; Minken A; Bentzen SM; Lambin P
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):132-8. PubMed ID: 18037581
[TBL] [Abstract][Full Text] [Related]
34. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
35. Tumor induction following intraoperative radiotherapy: late results of the National Cancer Institute canine trials.
Barnes M; Duray P; DeLuca A; Anderson W; Sindelar W; Kinsella T
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):651-60. PubMed ID: 2120159
[TBL] [Abstract][Full Text] [Related]
36. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
[TBL] [Abstract][Full Text] [Related]
37. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
38. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Meijer G; Steenhuijsen J; Bal M; De Jaeger K; Schuring D; Theuws J
Radiother Oncol; 2011 Sep; 100(3):396-401. PubMed ID: 21955663
[TBL] [Abstract][Full Text] [Related]
39. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results.
King SC; Acker JC; Kussin PS; Marks LB; Weeks KJ; Leopold KA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):593-9. PubMed ID: 8948343
[TBL] [Abstract][Full Text] [Related]
40. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
